interleukin-4 small interfering RNA

Interleukin-4 small interfering RNA is an experimental **small interfering RNA** therapeutic designed to silence **interleukin-4** messenger RNA and thereby reduce IL-4 expression. In the cited preclinical literature, it was studied as a locally delivered RNA interference approach to suppress Th2-driven airway inflammation, including virus-induced asthma exacerbation models and allergic airway disease models. The available context supports it as a research-stage, noncommercialized sequence-specific IL-4 gene-silencing agent rather than a uniquely branded clinical drug product, with development centered on academic preclinical evaluation for inflammatory airway diseases such as asthma and allergic rhinitis.

Other names

interleukin-4 small interfering ribonucleic acidinterleukin4 small interfering ribonucleic acidinterleukin 4 small interfering ribonucleic acidIL-4 siRNAIL4 siRNAIL 4 siRNAsmall interfering RNA targeted to interleukin-4